Results 201 to 210 of about 30,002 (370)

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

open access: yesVIEW, EarlyView.
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification.
Yuhui Ma   +6 more
wiley   +1 more source

Multidisciplinary Management of an Anterior Skull Base Teratoma in a Neonate. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Allison SG   +5 more
europepmc   +1 more source

Multimodal management of PD‐L1 positive sinonasal inverted papilloma with malignant transformation

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
Abstract Inverted papillomas (IP) are rare sinonasal tumors (Schneiderian papillomas) characterized by local invasion, with high recurrence rates and potential for malignant transformation into squamous cell carcinoma (SCC ex‐IP). Traditionally, the mainstay of treatment has been surgical resection, often challenging due to invasion of the skull base ...
Vanessa Velazquez   +3 more
wiley   +1 more source

Role of Cancer Associated Fibroblast (CAF) derived miRNAs on head and neck malignancies microenvironment: a systematic review. [PDF]

open access: yesBMC Cancer
Golestannejad P   +12 more
europepmc   +1 more source

Pituitary adenoma management and outcomes according to hospital case volume and facility type

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
Abstract Objectives This study evaluates the influence of facility volume and type on the treatment and outcomes of pituitary adenoma (PA). Methods The 2004–2016 National Cancer Database was queried for patients with PA receiving definitive treatment. Tumor size represented the largest diameter of the primary tumor.
Khodayar Goshtasbi   +8 more
wiley   +1 more source

Developing a multi‐modal MRI radiomics‐based model to predict the long‐term overall survival of patients with hypopharyngeal cancer receiving definitive radiotherapy

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
Abstract Objective The aim of this study is to develop a multimodal MRI radiomics‐based model for predicting long‐term overall survival in hypopharyngeal cancer patients undergoing definitive radiotherapy. Methods We enrolled 207 hypopharyngeal cancer patients who underwent definitive radiotherapy and had 5‐year overall survival outcomes from two major
Xi‐Wei Zhang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy